查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726137

流式細胞技術市場規模、佔有率、趨勢分析報告：按產品、技術、最終用途、地區和細分市場預測，2025 年至 2030 年

Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables, Software, Accessories, Services), By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 166 Pages | 商品交期: 2-10個工作天內

價格

流式細胞技術市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球流式細胞技術市場規模預計到2030年將達到70.131億美元，預計2025年至2030年期間的複合年成長率為8.41%。

技術進步正在引入新的和改進的分析工具，例如用於即時檢驗（PoC）的微流體流式細胞技術的開發。此外，癌症、免疫力缺乏和感染疾病的發病率上升也在推動該產業的發展。此外，生物製藥、生命科學和生物技術研究活動的研發投入不斷增加，導致對流式細胞技術儀的需求量很大。最近的趨勢主要集中在用於 PoC 測試的攜帶式微流體流式細胞技術儀的開發。

微射流與流式細胞技術相結合，為測量生物樣本的多種特性提供了有用的工具。例如，多種微流體和微型檢測器的現成可用性促進了基於微晶片的細胞分析儀（如光流體細胞分析儀、成像細胞分析儀和電阻細胞分析儀）的開發。微流體流式細胞技術儀的開發具有成本低、便攜、緊湊、效益高等特點。這些產品價格實惠，在亞洲和非洲的新興經濟體中均可買到，推動了 PoC 測試應用的快速成長。此外，螢光染料的改進和學術研究環境中桌上型細胞分析儀的效用普及有望推動該產業的發展。

多色流式細胞技術的發展加速了該技術在開發新藥活動中的應用。例如，2020年1月，貝克曼庫爾特生命科學公司在歐洲推出了13色臨床流式細胞技術系統DxFLEX，CE-IVD。同樣，由於細胞分析的簡單性和同時評估多個參數的能力，使得此類儀器被廣泛用於合約研究目的。新冠疫情也刺激了技術創新，該領域新產品的推出就是明證。例如，2021 年 7 月，Metropolis Healthcare Ltd. 推出了 CoviRisk-TBNK，這是一項簡單的血液測試，用於檢測住院 COVID-19 患者的風險狀況。

此測試將有助於評估重症監護病房 (ICU) 入院和機械通氣的必要性，從而減輕醫療資源的壓力。此測試是流式細胞技術的淋巴細胞亞群檢測，已核准用於體外診斷。預計此類技術創新將在不久的將來推動產業成長。此外，流式細胞技術是計數和表徵免疫細胞的重要工具，也有助於識別和檢驗潛在的遺傳缺陷。該技術也用於觀察和監測患者幹細胞移植後的免疫反應，使器官移植成為該產業成長的主要驅動力。根據世界衛生組織統計，全球每年進行約5萬例幹細胞移植手術，預計未來數字將成長，並擴大該技術的應用範圍。

另一方面，發展中國家可能無法負擔技術先進的流式細胞技術設備，因為該設備非常昂貴。這些儀器的價格可能超過 10 萬美元，對中小型醫院和臨床實驗室的預算造成了巨大的限制。然而，索尼等一些製造商正嘗試推出配備可自動執行許多流程的軟體的新型設備。這些發展不僅使該技術更易於使用，而且還將有助於在不久的將來降低平均設備成本（低於 100,000 美元）。

流式細胞技術市場報告重點

  • 到2024年，由於技術進步帶來的滲透率提高，設備部門將以35.30%的最大收入佔有率引領市場。
  • 從技術角度來看，到 2024 年，基於細胞的細分市場將佔據市場主導地位，收入佔有率最大，達到 76.16%。
  • 按應用分類，臨床領域佔據市場主導地位，2024 年的收入佔有率最大，為 45.34%。
  • 根據最終用途，由於流式細胞技術在細胞生物學和分子診斷中的廣泛應用，學術機構部門將在 2024 年佔據最大的收益佔有率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章流式細胞技術市場變數、趨勢和範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 流式細胞技術市場分析工具
    • 波特分析
    • PESTEL分析

第4章流式細胞技術市場：產品、估計和趨勢分析

  • 流式細胞技術市場：產品差異分析
  • 流式細胞技術市場：產品差異分析，百萬美元，2024 年對比 2030 年
  • 裝置
    • 細胞分析設備
    • 電池分選設備
  • 試劑和耗材
  • 軟體
  • 配件
  • 服務

第5章流式細胞技術市場：依技術、估計和趨勢分析

  • 流式細胞技術市場：技術波動分析
  • 流式細胞技術市場：技術差異分析，百萬美元，2024 年 vs 2030 年
  • 基於細胞
  • 以微珠為基礎

第6章流式細胞技術市場：按應用的估計和趨勢分析

  • 流式細胞技術市場：應用差異分析
  • 流式細胞技術市場：應用差異分析，百萬美元，2024 年對比 2030 年
  • 研究
    • 製藥
    • 藥物凋亡
    • 細胞分選
    • 細胞週期分析
    • 免疫學
    • 細胞活力
  • 產業
  • 臨床
    • 癌症
    • 器官移植
    • 免疫力缺乏
    • 血液學
    • 自體免疫疾病

第7章流式細胞技術市場：最終用途、估計和趨勢分析

  • 流式細胞技術市場：最終用途變異分析
  • 流式細胞技術市場：最終用途差異分析，百萬美元，2024 年 vs. 2030 年
  • 臨床檢測實驗室
  • 學術機構
  • 商業組織
    • 生技公司
    • 製藥公司
    • CRO
  • 醫院

第8章流式細胞技術市場：區域、估計和趨勢分析

  • 2024 年和 2030 年流式細胞技術市場佔有率（按地區分類，百萬美元）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Danaher
    • BD
    • Sysmex Corporation
    • Apogee Flow Systems Ltd.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Stratedigm, Inc.
    • Miltenyi BIoTec
    • Cytek Biosciences
    • Sony Group Corporation（Sony BIoTechnology Inc.）
Product Code: GVR-1-68038-412-3

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is estimated to reach USD 7,013.1 million by 2030, registering to grow at a CAGR of 8.41% from 2025 to 2030 according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments. In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications. Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes. The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future. Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

  • The instrument segment led the market with the largest revenue share of 35.30% in 2024 with owing to higher penetration driven by technological developments.
  • Based on technology, the cell-based segment led the market with the largest revenue share of 76.16% in 2024.
  • Based on application, the clinical segment led the market with the largest revenue share of 45.34% in 2024.
  • Based on end use, the academic institutes segment accounted for the largest revenue share in 2024, driven by the extensive use of flow cytometry in cell biology and molecular diagnostics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Flow Cytometry Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Growing prevalence of chronic and infectious diseases
      • 3.3.1.2. High R&D investments in biotechnology, clinical, and life science research
      • 3.3.1.3. Technological advancements in flow cytometry instruments and reagents
      • 3.3.1.4. Increasing demand for point-of-care diagnostics
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of instruments
  • 3.4. Flow Cytometry Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Flow Cytometry Market: Product Estimates & Trend Analysis

  • 4.1. Flow Cytometry Market: Product Movement Analysis
  • 4.2. Flow Cytometry Market: Product Movement Analysis, USD Million, 2024 & 2030
  • 4.3. Instruments
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Cell Analyzers
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Cell Sorters
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reagents & Consumables
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Services
    • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Flow Cytometry Market: Technology Estimates & Trend Analysis

  • 5.1. Flow Cytometry Market: Technology Movement Analysis
  • 5.2. Flow Cytometry Market: Technology Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Cell-based
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Bead-based
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Flow Cytometry Market: Application Estimates & Trend Analysis

  • 6.1. Flow Cytometry Market: Application Movement Analysis
  • 6.2. Flow Cytometry Market: Application Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Research
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Pharmaceutical
      • 6.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.2.2. Drug Discovery
        • 6.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.2.3. Drug In Vitro Toxicity
        • 6.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.3.2.4. Drug Stem Cell
        • 6.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Drug Apoptosis
      • 6.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Cell Sorting
      • 6.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Cell Cycle Analysis
      • 6.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Immunology
      • 6.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Cell Viability
  • 6.4. Industrial
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Clinical
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Cancer
      • 6.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Organ Transplantation
      • 6.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Immunodeficiency
      • 6.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Hematology
      • 6.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Autoimmune Disorders

Chapter 7. Flow Cytometry Market: End Use Estimates & Trend Analysis

  • 7.1. Flow Cytometry Market: End Use Movement Analysis
  • 7.2. Flow Cytometry Market: End Use Movement Analysis, USD Million, 2024 & 2030
  • 7.3. Clinical Testing Labs
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Academic Institutes
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Commercial Organizations
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Biotechnology Companies
      • 7.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Pharmaceutical Companies
      • 7.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. CROs
  • 7.6. Hospitals
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Flow Cytometry Market: Regional Estimates & Trend Analysis

  • 8.1. Flow Cytometry Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.2.2. Country Dynamics
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.3.2. Country Dynamics
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.2.4.2. Country Dynamics
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Scenario
  • 8.3. Europe
    • 8.3.1. Europe Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.2. Country Dynamics
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.3.2. Country Dynamics
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Scenario
    • 8.3.4. France
      • 8.3.4.1. France Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.4.2. Country Dynamics
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.5.2. Country Dynamics
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.6.2. Country Dynamics
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.7.2. Country Dynamics
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.8.2. Country Dynamics
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.3.9.2. Country Dynamics
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.2.2. Country Dynamics
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Scenario
    • 8.4.3. China
      • 8.4.3.1. China Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.3.2. Country Dynamics
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Scenario
    • 8.4.4. India
      • 8.4.4.1. India Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.4.2. Country Dynamics
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Scenario
    • 8.4.5. Australia
      • 8.4.5.1. Australia Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.5.2. Country Dynamics
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Scenario
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.6.2. Country Dynamics
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.4.7.2. Country Dynamics
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.5.2.2. Country Dynamics
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.5.3.2. Country Dynamics
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Scenario
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.2.2. Country Dynamics
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.3.2. Country Dynamics
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.4.2. Country Dynamics
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 8.6.5.2. Country Dynamics
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Scenario

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Danaher
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. BD
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Sysmex Corporation
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Apogee Flow Systems Ltd.
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Bio-Rad Laboratories, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Thermo Fisher Scientific, Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Stratedigm, Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Miltenyi Biotec
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Cytek Biosciences
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Sony Group Corporation (Sony Biotechnology Inc.)
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
  • Table 3 CPT codes for flow cytometry reimbursement
  • Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 22 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 23 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 25 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 26 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 27 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 28 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 30 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 31 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 32 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 34 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 35 UK flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 36 UK flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 38 UK flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 39 France flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 40 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 41 France flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 42 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 43 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 44 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 46 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 47 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 48 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 50 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 51 Denmark flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 52 Denmark flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Denmark flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 54 Denmark flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 55 Sweden flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 56 Sweden flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Sweden flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 58 Sweden flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 59 Norway flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 60 Norway flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Norway flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 62 Norway flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 63 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 64 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 65 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 67 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 68 China flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 69 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 70 China flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 71 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 72 India flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 73 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 74 India flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 75 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 76 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 77 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 79 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 80 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 82 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 83 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 84 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 85 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 86 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 87 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 88 Thailand flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 89 Thailand flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Thailand flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 91 Thailand flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 92 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 93 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 94 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 96 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 97 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 98 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 99 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 100 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 101 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 102 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 103 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 104 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 105 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 106 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 107 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 108 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 109 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 110 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 111 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 112 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 113 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 118 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 119 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 120 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 121 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Kuwait flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 125 Kuwait flow cytometry market, end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Volume price analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook (2024)
  • Fig. 15 Flow cytometry market driver impact
  • Fig. 16 Flow cytometry market restraint impact
  • Fig. 17 Porter's five force analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Flow cytometry market: product outlook & key takeaways
  • Fig. 20 Flow cytometry market: product movement analysis
  • Fig. 21 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 22 Global cell analyzers market, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell sorters market, 2018 - 2030 (USD Million)
  • Fig. 24 Global reagents & consumables market, 2018 - 2030 (USD Million)
  • Fig. 25 Global software market, 2018 - 2030 (USD Million)
  • Fig. 26 Global accessories market, 2018 - 2030 (USD Million)
  • Fig. 27 Global services market, 2018 - 2030 (USD Million)
  • Fig. 28 Flow cytometry market: technology outlook & key takeaways
  • Fig. 29 Flow cytometry market: technology movement analysis
  • Fig. 30 Global cell-based market, 2018 - 2030 (USD Million)
  • Fig. 31 Global bead-based market, 2018 - 2030 (USD Million)
  • Fig. 32 Flow cytometry market: application outlook & key takeaways
  • Fig. 33 Flow cytometry market: application movement analysis
  • Fig. 34 Global research application market, 2018 - 2030 (USD Million)
  • Fig. 35 Global pharmaceutical application market, 2018 - 2030 (USD Million)
  • Fig. 36 Global drug discovery application market, 2018 - 2030 (USD Million)
  • Fig. 37 Global in vitro toxicity application market, 2018 - 2030 (USD Million)
  • Fig. 38 Global stem cell application market, 2018 - 2030 (USD Million)
  • Fig. 39 Global apoptosis application market, 2018 - 2030 (USD Million)
  • Fig. 40 Global cell sorting application market, 2018 - 2030 (USD Million)
  • Fig. 41 Global cell cycle analysis application market, 2018 - 2030 (USD Million)
  • Fig. 42 Global immunology application market, 2018 - 2030 (USD Million)
  • Fig. 43 Global cell viability application market, 2018 - 2030 (USD Million)
  • Fig. 44 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 45 Global industrial application market, 2018 - 2030 (USD Million)
  • Fig. 46 Global clinical application market, 2018 - 2030 (USD Million)
  • Fig. 47 Global cancer application market, 2018 - 2030 (USD Million)
  • Fig. 48 Global organ transplantation application market, 2018 - 2030 (USD Million)
  • Fig. 49 Global immunodeficiency application market, 2018 - 2030 (USD Million)
  • Fig. 50 Global hematology application market, 2018 - 2030 (USD Million)
  • Fig. 51 Global autoimmune disorders market, 2018 - 2030 (USD Million)
  • Fig. 52 Flow cytometry market: end use outlook & key takeaways
  • Fig. 53 Flow cytometry market: end use movement analysis
  • Fig. 54 Global commercial organizations market, 2018 - 2030 (USD Million)
  • Fig. 55 Global biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 56 Global pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 57 Global CROs market, 2018 - 2030 (USD Million)
  • Fig. 58 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 59 Global academic institutes market, 2018 - 2030 (USD Million)
  • Fig. 60 Global clinical testing labs market, 2018 - 2030 (USD Million)
  • Fig. 61 Regional marketplace: key takeaway
  • Fig. 62 Flow cytometry market: regional movement analysis
  • Fig. 63 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)